CoChat

Intranasal insulin activates Akt2 signaling pathway in the hippocampus of wild-type but not in APP/PS1 Alzheimer model mice

Open access
Gabbouj, Sami, Natunen, Teemu, Koivisto, Hennariikka, Jokivarsi, Kimmo, Takalo, Mari, Marttinen, Mikael, Wittrahm, Rebekka, Kemppainen, Susanna, Naderi, Reyhaneh, Posado-Fernández, Adrián, Ryhänen, Simo, Mäkinen, Petra, Paldanius, Kaisa M.A., Doria, Gonçalo, Poutiainen, Pekka, Flores, Orfeu, Haapasalo, Annakaisa, Tanila, Heikki, Hiltunen, Mikko · 2019 · Neurobiology of Aging
Cited by 34

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Abstract

Type 2 diabetes mellitus (T2DM) increases the risk for Alzheimer's disease (AD). Human AD brains show reduced glucose metabolism as measured by [18F]fluoro-2-deoxy-2-D-glucose positron emission tomography (FDG-PET). Here, we used 14-month-old wild-type (WT) and APP Swe /PS1 dE9 (APP/PS1) transgenic mice to investigate how a single dose of intranasal insulin modulates brain glucose metabolism using FDG-PET and affects spatial learning and memory. We also assessed how insulin influences the activity of Akt1 and Akt2 kinases, the expression of glial and neuronal markers, and autophagy in the hippocampus. Intranasal insulin moderately increased glucose metabolism and specifically activated Akt2 and its downstream signaling in the hippocampus of WT, but not APP/PS1 mice. Furthermore, insulin differentially affected the expression of homeostatic microglia markers P2ry12 and Cx3cr1 and autophagy in the hippocampus of WT and APP/PS1 mice. We found no evidence that a single dose of intranasal insulin improves overnight memory. Our results suggest that intranasal insulin exerts diverse effects on Akt2 signaling, autophagy, and the homeostatic status of microglia depending on the degree of AD-related pathology.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.neurobiolaging.2018.11.008

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 15 references

Cited by

See all 34

Metadata

Authors
Gabbouj, S., Natunen, T., Koivisto, H., Jokivarsi, K., Takalo, M., Marttinen, M., Wittrahm, R., Kemppainen, S., Naderi, R., Posado-Fernández, A., Ryhänen, S., Mäkinen, P., Paldanius, K. M. A., Doria, G., Poutiainen, P., Flores, O., Haapasalo, A., Tanila, H., & Hiltunen, M.
Venue
Neurobiology of Aging
Publisher
Elsevier BV
Published
2019-03
Volume
75
Pages
98-108
ISSN
0197-4580 (ISSN-L)
OpenAlex
W2900656160
Cited by
34
References
15
FWCI
2.52
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Intranasal insulin activates Akt2 signaling pathway in the hippocampus of wild-type but not in APP/PS1 Alzheimer model mice. https://app.cochat.ai/papers/10.1016/j.neurobiolaging.2018.11.008
The paper
Gabbouj, S., Natunen, T., Koivisto, H., Jokivarsi, K., Takalo, M., Marttinen, M., Wittrahm, R., Kemppainen, S., Naderi, R., Posado-Fernández, A., Ryhänen, S., Mäkinen, P., Paldanius, K. M. A., Doria, G., Poutiainen, P., Flores, O., Haapasalo, A., Tanila, H., & Hiltunen, M. (2019). Intranasal insulin activates Akt2 signaling pathway in the hippocampus of wild-type but not in APP/PS1 Alzheimer model mice. Neurobiology of Aging. https://doi.org/10.1016/j.neurobiolaging.2018.11.008

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.